Ewing Sarcoma Breakpoint Region 1 (EWSR1) (C-Term) Peptide
EWSR1
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all EWSR1 products
- EWSR1 (Ewing Sarcoma Breakpoint Region 1 (EWSR1))
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- SQQNTYGQPS SYGQQSSYGQ QSSYGQQPPT SYPPQTGSYS QAPSQYSQQS
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-EWSR1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- EWSR1 (Ewing Sarcoma Breakpoint Region 1 (EWSR1))
- Background
-
EWSR1 is a putative RNA binding protein. Mutations in this gene, specifically a t(11,22)(q24,q12) translocation, are known to cause Ewing sarcoma as well as neuroectodermal and various other tumors.
Protein Size: 354 - Gene ID
- 2130
-
You are here:
